Study to Assess Real Life Effectiveness of Foslevodopa/Foscarbidopa in Adult German Participants at Initial Stages of Advanced Parkinson's Disease (EARLY-FOS) Trial N/A Recruiting Oct. 1, 2026
Artificial Intelligence-based Parkinson's Disease Risk Assessment (AI-PRA) Study Trial N/A Not yet recruiting Oct. 1, 2026
Enabling Women With Parkinson's Disease to Identify and Better Manage Hormonal Triggers of Parkinsonian Symptoms Trial N/A Recruiting Oct. 1, 2026
Occupation-Based Cognitive Stimulation With and Without Motivational Feedback in Parkinson's Disease Trial N/A Not yet recruiting Sept. 30, 2026
Study of the Test-retest Reliability of the Neuropsychiatric Fluctuations Scale in Parkinson's Disease Trial N/A Recruiting Sept. 29, 2026
Effects of Excitatory and Inhibitory LIFUS of GPi in Parkinsonian Patients Without DBS Trial N/A Recruiting Sept. 28, 2026
A Manualized Recreational Therapy Balance Program for Older Adults With Parkinson's and Movement Disorders Trial N/A Not yet recruiting Sept. 28, 2026
The Efficacy of Psilocybin Therapy for Depression in Parkinson's Disease Trial Phase 2 Recruiting Sept. 27, 2026
A Two-Part Single and Multiple Ascending Dose Trial of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LBT-3627 in Healthy Participants and in Participants With Parkinson's Disease. Trial Phase 1 Recruiting Sept. 24, 2026
Acute Effects of Capacitive-Resistive Radiofrequency Therapy in People With Parkinson's Disease Trial N/A Recruiting Sept. 24, 2026
Effects of Transcutaneous Cervical Vagus Nerve Stimulation on Non-motor Symptoms in Parkinson's Disease Trial N/A Not yet recruiting Sept. 23, 2026
Investigating Adaptive Deep Brain Stimulation in Parkinson's Disease Management Trial N/A Recruiting Sept. 23, 2026
Assessment of the Safety, Immunogenicity, and Pharmacodynamics of TRB-001 in Patients With Early Idiopathic Parkinson's Disease Trial Phase 1 Recruiting Sept. 23, 2026
Effects of Repetitive Transcranial Magnetic Stimulation (rTMS)-Primed Self-controlled Practice in People With Parkinson's Disease Trial N/A Recruiting Sept. 21, 2026